Lupus & antiphospholipid syndrome

Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation

Rheumatology (Oxford)Published Retrospective cohort study

Authors' conclusion

Male sex, younger age and serological activity at SLE diagnosis are strongly associated with subsequent kidney involvement.

Study context

Population
Patients with SLE from the 'Attikon' Lupus cohort; validation in the University of Crete Lupus registryderivation cohort
Participants
570 patients
Exposure
Baseline characteristics of patients with SLE who developed LN vs those who did not
Outcome
Incident LN, defined by kidney histology and/or classification criteria
Methodological detailsindependent validation cohort, multivariate Cox proportional hazards model
  • Independent validation cohort
  • Multivariate Cox proportional hazards model

Main finding

As reported in the abstract

Baseline predictors of subsequent LN (66 patients developing LN during follow-up)
Adjusted hazard ratio (95% CI)P value
Male sex
4.31(1.82–10.2)
Age of SLE diagnosis below 26 years
3.71(1.84–7.48)
High anti-dsDNA titre
2.48(1.03–5.97)
Low C3 and/or C4
2.24(0.83–6.05)
P = 0.11
Combination of these factors at diagnosisvs Serologically inactive, older, female patientsalmost 90-fold risk; very high-risk group
88.77(18.75–420.41)

Observational data: associations, not effects.

Further findings

LN incidence (initial presentation plus during follow-up)

LN as initial presentation
59
LN developed during follow-up
66
Collective incidence
21.9%

Independent validation in the Crete Lupus registry

Concordant results with the original cohort

Original publication

Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation. Rheumatology (Oxford). Published 15 May 2024. doi:10.1093/rheumatology/keae278

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.